23rd Annual Biotech in Europe Forum 2023 | Sachs Associates Ltd | 19 September 2023 | Movenpick Hôtel Bâle, Aeschengraben 25, 4051 Basel, Switzerland

In addition, there will be a global company showcase of 60+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate about 550 delegates will register for the forum from all sectors of Life Sciences, with the target audience being corporate and financial investors/partners, banks and advisors, with part of the audience participating virtually.

2023 Speakers

Alex Blyth
CEO, LIfT BioSciences Ltd.

Alex Hamilton
Investment Partner, Syncona Investment Management Ltd.

Alexander Gebauer
CEO, Secarna Pharmaceuticals GmbH & Co. KG

Andrea Malizia
CEO, IAMA Therapeutics S.r.l.

Antti Vuolanto
CEO, Herantis Pharma Plc

Asun Monfort
Investment Professional - Investment Advisor Private Equity, HBM Partners AG

Carlos Buesa
Founder & CEO, Oryzon Genomics, S.A.

Carolin Barth
Partner & Director, Boston Consulting Group

Catherine Pickering
CEO, iOnctura SA

Christoph Broja
Investment Advisory Professional - Managing Director, EQT Life Sciences

Claudia Ulbrich
CEO, Cardior Pharmaceuticals GmbH

Colette Lipp
Director, Global Oncology and Immuno-Oncology Licensing & Business Development, Merck KGaA, Darmstadt, Germany

Corinne Venot
Executive Director BD&L, BeiGene Ltd.

Dimitrios Weedon-Topalopoulos
Managing Director, OrbiMed Advisors LLC

Dmitrij Hristodorov
Partner, Forbion

Eric Halioua
President & CEO, PDC*line Pharma SA

Esteban Pombo-Villar
CTO, TargImmune Therapeutics AG

Fintan Walton
Founder & CEO, PharmaVentures Ltd.

François Thomas
Operating Partner, Quadrille Capital

Giovanni Rizzo
Partner Biotech Fund, Indaco Venture Partners SGR S.p.A.

Giulia Vestri
Head of Business Development, Azafaros B.V.

Hakan Goker
Managing Director, M Ventures

Hermann-Josef Kaiser
VP, Business Development, ARMGO Pharma, Inc.

Hiro Usuda
Senior Manager, Business Development, Astellas Pharma Europe Ltd.

Hubert Birner
Managing Partner, TVM Capital Life Science

Inmaculada Valle
Investment Manager, European Investment Fund

Jenny Laird
VP, Search & Evaluation Neuroscience, Eli Lilly and Company

Jesus Baena
BD&L Partnering Director, Novartis Pharma AG

Jesús Martin-Garcia
CEO, GeNeuro SA

Kaspar Sutter
State Councillor, Department of Economic, Social and Environmental Affairs, Canton of Basel-Stadt

Katya Smirnyagina
Senior Partner (Life Sciences), Oxford Science Enterprises

Kelly Curtin
Managing Director, Stifel

Konstantin Petropoulos
CEO, sterna biologicals GmbH

Laura Lane
VP, Lilly Ventures – Europe Head External Innovation, Eli Lilly and Company

Luc Boblet
Co-Founder & CEO, Egle Therapeutics SAS

Magne Stoknes
Principal, Novo Holdings A/S

Mankit Law
Director, Business Development, GSK

Marianne Uteng
Managing Director, Novartis Venture Fund

Markus Kalousek
CBO / Venture Partner, ViGeneron / BGV

Michael Altorfer
CEO, Swiss Biotech Association

Michael Hübner
Director Early Innovation Partnering, Johnson & Johnson Innovation LLC

Mireia Gómez-Angelats
CBO, Topas Therapeutics GmbH

Nicolas Poirier
CEO & CSO, OSE Immunotherapeutics

Nigel Sheail
Venture Partner, Versant Ventures

Pascal Neuville
CEO, Domain Therapeutics SA

Paul Bravetti
CEO, Brenus Pharma

Paul Hermant
Partner, Bird & Bird LLP

Paul Rennert
CEO, Aleta Biotherapeutics

Per Norlén
CEO, Evaxion Biotech A/S

Peter Kahr
Senior Medical Director, Neurimmune AG

Peter Louwagie
Head BD&L Partnering Immunology, Novartis AG

Rainer Strohmenger
Managing Partner, Wellington Partners

Regina Hodits
Managing Partner, Wellington Partners

Richard War
Executive Director, Search & Evaluation, AstraZeneca

Robbie McLaren
Partner & Global Vice Chair of the Healthcare & Life Sciences Industry Group, Latham & Watkins LLP

Sam Fazeli
Head of Research, Senior Pharmaceuticals Analyst, Bloomberg Intelligence

Sandra von Meier
Head Business Development & Licensing, Debiopharm International S.A.

Sara Nunez-Garcia
Founding Partner, Forty51 Ventures

Simon Molgaard
Co-Founder & CEO, Teitur Trophics

Søren Møller
Managing Partner, Novo Holdings A/S

Stefan Luzi
Partner, Gilde Healthcare Partners

Stephan Emmerth
Director, BaseLaunch

Stéphane Boissel
President & CEO, SparingVision

Stéphane Degove
CEO, Atamyo Therapeutics SAS

Stephanie Léouzon
Managing Director, Stifel

Stephen Sullivan
COO, iPSirius

​Suzanne Saffie-Siebert
Chairwoman & CEO, SiSaf Ltd.

Tahera Kan
VP, Global Business Development Precision Medicine, Johnson & Johnson Innovation | Janssen Business Development

Ulrich Wendt
Head of Immunology Business Development, Sanofi

Victoria English
Co-founder & Editor, MedNous

Yanina Lenz
Senior Director, Scientific Licensing, BD&L & Alliance Management, Pharmaceuticals, Bayer AG

2023 Sponsors

SILVER SPONSORS:
• Basel
• Stifel

BRONZE SPONSORS:
• Invest Hong Kong
• Merck KGaA

CONTRIBUTING SPONSORS:
• Kanton Basel-Stadt
• Latham & Watkins LLP
• Novo Ventures
• PharmaVentures